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SUMMARY
It is generally believed that hepatitis B (HBV) and C (HCV) viruses are highly prevalent in the
Republic of Yemen. This study investigated the prevalence of HBV and HCV markers in 494
blood donors from Aden, 493 blood donors from Sana’a, 97 residents from an African ethnic
minority in Sana’a and 99 residents of Soqotra Island. There were signiﬁcant diﬀerences in the
prevalence of HBV carriage (HBsAg: 6.7, 15, 19.6 and 26.3% respectively ; P<0.001); past HBV
infection (anti-HBc: 17.4, 18.5, 30.9 and 59.6% respectively ; P<0.001); susceptibility to HBV
(absence of HBV markers : 73.3, 61.9, 38.1 and 9.1% respectively ; P<0.001), infectivity of
HBV carriers (HBV DNA: 51.5, 33.8, 52.6 and 65.4% respectively ; P=0.028) and HCV antibodies
(RIBA conﬁrmed or indeterminate: 0.6, 0.2, 5.2 and 5.1% respectively ; P<0.001). A signiﬁcant
diﬀerence in HBV carrier rate and a borderline signiﬁcant diﬀerence in the prevalence of natural
infection was observed between males and females in the African community (P=0.02 and 0.06
respectively). In contrast, in Soqotra Island, there was no signiﬁcant sex diﬀerence in HBV carrier
rate but susceptibility was signiﬁcantly more prevalent in males (P=0.03). This study illustrates
that signiﬁcant diﬀerence in prevalence and epidemiology exists among diﬀerent communities
within the same country, reﬂecting political, geographical and social diﬀerences. Control
strategies should take these diﬀerences into account.
INTRODUCTION
Infection with hepatitis B (HBV) and C (HCV) causes
major health problems. It is estimated that more
than two billion individuals worldwide have evidence
of previous or current HBV infection and at least
350 million are chronic carriers [1]. For HCV, it is
estimated that worldwide at least 170 million are
chronically infected [2].
Three levels of HBV endemicity are recognized –
high endemicity, where the carrier rate is 8–15% and
prevalence of infection is 40–90%; intermediate, with
respective rates of between 2–7 and 16–55% and low,
where the rates are 0.1–1 and 4–15% respectively [3].
Among the Middle Eastern countries, Bahrain, Iran
and Kuwait have low endemicity; and Cyprus, Iraq
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and United Arab Emirates intermediate endemicity,
whereas Egypt, Jordan, Oman, Palestine, Yemen and
Saudi Arabia have high endemicity [4]. The prevalence
of HCV is also variable. A prevalence of 20% has
been reported from Egypt [5], whereas only 3.3% of
Saudi Arabian [6] and 0.95% of Syrian blood donors
are infected [7].
Few studies have examined the prevalence of HBV
and HCV in Yemen. Scott reported an HBV surface
antigen (HBsAg) carrier rate of 12.7% among the gen-
eral population [8] and a prevalence of HCV of 2.6%
[9], while Al-Robasi and Al-Harbi reported an HBsAg
prevalence of 9% among blood donors [10]. These
studies did not, however, consider the eﬀect of geo-
graphical, cultural or social diﬀerences on the preva-
lence of these viruses across the country. Until 12 years
ago, the Republic of Yemen consisted of two separate
countries (currently the Northern and Southern re-
gions). The Northern region was an Arab state and
the Southern region a socialist republic. In addition,
some ethnic minorities originating from Africa live
in close communities and poor socio-economic con-
ditions. This may have resulted in diﬀerent trans-
mission patterns and prevalence of hepatitis viruses.
The present study examines the prevalence of HBV
and HCV in blood donors attending the blood bank
services of Sana’a and Aden in the Northern and
Southern regions, a group of residents of Soqotra
Island, in the Indian Ocean and an African ethnic
minority from a shanty town of Sana’a.
METHODS
Subjects
Blood donors attending the national blood bank
services of Sana’a (n=493) and Aden (n=494) were
recruited consecutively. Previous and current residence
was ascertained to allow adjustment for migration.
Blood donation operates on a semi-voluntary basis in
which relatives and friends of patients are requested
to donate blood for their clinical management. For
cultural reasons, only youngmaleswho consider them-
selves healthy donate blood. Although all blood is
checked for blood-borne viruses, there is no recall
system to inform donors of their possible infectious
status. In addition, 99 subjects from Soqotra Island
and 97 from an African ethnic community living in a
shanty town of Sana’a were randomly selected after
informed consent by house to house visits by outreach
teams. The map in Figure 1 illustrates the location of
these areas.
Serology
Sera were anonymized and screened for HBsAg
(Monolisa Ag HBs Plus; Sanoﬁ Pasteur, France) in
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Fig. 1.Map of Yemen with the geographical area of the participants. The African community resided within the city of Sana’a.
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the Faculty of Medicine and Health Sciences at the
University of Sana’a. Reactive sera were further con-
ﬁrmed by neutralization (Murex HBsAg version 3,
Abbott, USA) whereas non-reactive sera were tested
for HBV core antibody (anti-HBc) (Monolisa HBc
Plus ; Sanoﬁ Pasteur, France). Anti-HBc non-reactive
sera were further tested for HBV surface antibody
(anti-HBs) (Monolisa anti-HBs Plus; Sanoﬁ Pasteur,
France). All conﬁrmed HBsAg positive sera were
further tested for antibody against hepatitis D virus
(anti-HDV) (DiaSorin ETI-AB-DELTAK-2). All sera
were tested for anti-HCV (Monolisa anti-HCV Plus
version 2; Sanoﬁ Pasteur, France) and reactive sera
were further conﬁrmed by the recombinant immuno-
blot assay (Chiron RIBA HCV 3.0 SIA, USA). The
presence of two or more speciﬁc bands on RIBA
was interpreted as a positive result according to the
manufacturer’s recommendation. To improve the
sensitivity, single band reactivity of RIBA, considered
by the manufacturer as an indeterminate result, was
also included in some analyses.
Molecular analysis
Viral nucleic acid was extracted using a standardized
guanidinium-based method and HBV DNA was de-
tected using an in-house polymerase chain reaction
(PCR) as previously described [11].
Deﬁnition of infection status
Carriage of HBV was deﬁned by the presence of
detectable HBsAg whereas the presence of anti-HBc
without HBsAg was taken to indicate past HBV in-
fection. Overall prevalence of HBV infection was de-
termined by the presence of HBsAg and/or anti-HBc.
The absence of any HBV markers (HBsAg, anti-HBc
and anti-HBs) was taken as an indicator of suscepti-
bility. Infectivity was measured by the presence of
HBV DNA among chronic carriers. The presence of
HCV antibody as conﬁrmed by RIBA was considered
as an indication of HCV infection. Samples with in-
determinate RIBA results were included for some,
but not all, analyses. The diﬀerences in prevalence
between the diﬀerent groups were computed and
analysed using the Epi-info 6 software (Center for
Disease Control, USA). Prevalences were compared
with Chi square, Chi square for trend or Fisher’s
exact test as appropriate.
RESULTS
All blood donors were male with a mean age of 27.4
(range 17–49) years. Fifty-one participants from the
African community were male and 46 female, with a
mean age of 26.9 (male 28.8, female 24; range 12–60)
years. Participants from Soqotra Island consisted of
51 males and 48 females with a mean age of 31.8 (male
33.5, female 30.4; range 5–80) years.
There was a signiﬁcant diﬀerence in HBV markers
between Sana’a and Aden (Table 1). Seventy-four
(15%) of the 493 blood donors from Sana’a and 33 of
the 494 (6.7%) blood donors from Aden had HBsAg
(P<0.0001). Similarly, evidence of natural infection
was observed in 165 (33.5%) donors from Sana’a but
in only 119 (24.1%) fromAden (P=0.001). Compared
to Sana’a, signiﬁcantly more donors in Aden lacked
HBV markers and were susceptible to HBV infection
(73.3% vs. 61.9%, P<0.001). Twenty-nine blood
donors from Sana’a were originally from Aden and 8
were from abroad. Among the blood donors in Aden,
Table 1. Viral hepatitis markers in four Yemeni communities
Blood
donors
Sana’a
%
positive
Blood
donors
Aden
%
positive
African
community
%
positive
Soqotra
Island
%
positive
P value
for trend
Number 493 494 97 99
HBsAg 74 15.0 33 6.7 19 19.6 26 26.3 <0.001
Anti-HBc 91 18.5 86 17.4 30 30.9 59 59.6 <0.001
HBsAg and anti-HBc 165 33.5 119 24.1 59 60.8 85 85.9 <0.001
Anti-HBs only 22 4.5 13 2.6 1 1.0 5 5.1
No HBV markers 305 61.9 362 73.3 37 38.1 9 9.1 <0.001
Anti-HCV* 1 0.2 3 0.6 5 5.2 5 5.1 <0.001
HBV DNA 25 33.8 17 51.5 10 52.6 17 65.4 0.028
Anti-HDV 0 0.0 0 0.0 0 0.0 0 0.0
* Include RIBA positive and indeterminate.
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13 had migrated from Sana’a and 5 from abroad. The
diﬀerences in the prevalence of HBV markers between
the North and South remained signiﬁcant after adjust-
ment for previous residence.
The HBsAg carrier rate among the African com-
munity was 19.6% (19/97) and 59 (60.8%) had evi-
dence of natural HBV infection. Of 99 Soqotran
subjects, 26 (20.2%) were HBsAg positive and 85
(85.9%) had evidence of natural HBV infection. Com-
paring HBVmarkers from these four groups, a signiﬁ-
cant diﬀerence was noted for markers of chronic
carriage (HBsAg), past infection (anti-HBc), preva-
lence of infection (HBsAg and anti-HBc), suscepti-
bility (absence of HBV markers) and infectivity of
carriers (HBV DNA).
Within the two minority communities, further
analysis was performed on sex-related diﬀerences in
the markers (Table 2). In the African community,
the carrier rate and prevalence of natural infection
were higher in males than females (P=0.02 and 0.06
respectively). There were no signiﬁcant carrier rate
diﬀerences between males and females in Soqotra
(P=0.52) but males were more susceptible than fe-
males (P=0.03). RIBA conﬁrmed HCV infection was
present in 1 (0.2%) of Sana’a and 1 (0.2%) of Aden’s
blood donors ; 2 (2.1%) of the African and 3 (3%)
Soqotrans. RIBA was indeterminate in 2 of the Aden
donors (0.4%), 3 (3.1%) Africans and 2 (2%) Soqo-
trans. There was a trend to higher HCV prevalence
in Soqotras and Africans than blood donors, but this
was only statistically signiﬁcant when samples with
indeterminate serology are included (P<0.001). None
of the HBsAg positive subjects had evidence of HDV
infection.
DISCUSSION
This is the ﬁrst report of geographical diﬀerences in the
prevalence of HBV in Yemen. The overall prevalence
of chronic HBV infection of 10.8% among healthy
blood donors conﬁrms that Yemen is an area with
high endemicity [8, 10, 12, 13]. The higher HBV carrier
rate and prevalence of natural infection in Sana’a
donors may reﬂect diﬀerent attitudes to blood do-
nation in Aden where altruistic donations are more
common. Another possible factor is the diﬀerent
socio-economic and health service provision before
uniﬁcation. The Southern Democratic Republic of
Yemen had links mostly with socialist countries while
the predominantly Arab North was heavily populated
with a capitalist infrastructure. The Northern region
also has a much larger population than the Southern
region (7.5 million vs. 2.3 million at 1988 before uni-
ﬁcation based on UNICEF report). Consequently,
the provision of health care to the larger and more
densely populated Northern region may be more dif-
ﬁcult than in the South. The number of blood donors
in this study is suﬃcient to investigate prevalence dif-
ferences between blood donors from Sana’a andAden.
However, as our blood donors were self-selected
young and healthymales, our ﬁndings need to be inter-
preted with care, especially when extrapolating to the
general population.
TheAfrican community in Sana’a represented a very
deprived minority with diﬀerent lifestyle and limited
access to health care. Soqotra Island is also a com-
munity with many links to Africa. Similar to the
African community in Sana’a, the island has a poor
infrastructure and the population has limited access
Table 2. Viral hepatitis markers in males and females in the African and Soqotran communities
African community Soqotra Island
Female
%
positive Male
%
positive P value Female
%
positive Male
%
positive P value
Number 46 51 48 51
HBsAg 4 7.8 15 29.4 0.02 12 23.5 14 27.5
Anti-HBc 19 37.3 21 41.2 32 62.7 27 52.9
HBsAg and anti-HBc 23 45.1 36 70.6 0.06 44 86.3 41 80.4
Anti-HBs only 1 2.0 0 0.0 3 5.9 2 3.9
No HBV markers 22 43.1 15 29.4 1 2.0 8 15.7 0.03
Anti-HCV* 2 4.3 3 5.9 1 2.0 4 7.8
HBV DNA 3 75.0 7 46.7 8 66.7 9 64.3
Anti-HDV 0 0.0 0 0.0 0 0.0 0 0.0
* Include RIBA positive and indeterminate.
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to health care. It is therefore not surprising that these
two communities had a signiﬁcantly higher HBV car-
rier rate and prevalence of infection. Soqotran and
African carriers were also more infectious than Sana’a
blood donors (65.4, 52.6 and 33.8% respectively)
although infectivity in Aden’s blood donors was
equally high (51.5%). In the African community,
males were more likely to be infected and to be carriers
than females whereas in Soqotra, males were more
susceptible to HBV. The number of participants in
these two latter groups however was too small to de-
termine diﬀerences in prevalence among subgroups of
these populations with enough statistical power. Fur-
ther studies with larger number of participants from
these two minority groups are therefore warranted.
The prevalence of HCV in the sample of Yemeni
blood donors was slightly lower than the 2.6% pre-
viously reported [9, 14]. This may be due to diﬀer-
ences in the selection of subjects. Unlike its neighbour
Egypt, Yemen has not undertaken large-scale par-
enteral antischistosomal therapy programmes [5],
which could account for the relatively low prevalence
of HCV infection in Yemen. The use of RIBA for
conﬁrmation may reduce the sensitivity of detection
as a drop in antibody levels may reduce the RIBA
reactivity to single band [15]. When samples with in-
determinate RIBA were included, the prevalence of
HCV in the African and Soqotran community was
signiﬁcantly higher than in blood donors. This is con-
sistent with the same mode of transmission and thus
the same risk factors of HBV and HCV.
This study demonstrates that the high prevalence
of HBV infection is not homogeneous across Yemen.
In addition, despite sharing similar routes of trans-
mission, HCV and HDV do not appear to be well
established in this population. This study indicates
that HBV prevalences can vary across communities
within the same country due to political, geographical
or social reasons. The recent introduction of universal
vaccination of all newborns in Yemen would help to
reduce the prevalence of infection in the long term.
However, more eﬀort is needed to reach the African
and Soqotran minority population in order to prevent
peri-natal transmission. An individual community
approach would be necessary when planning control
strategies.
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